Covid-19 roundup: Ger­many pours near­ly $450M in­to BioN­Tech; As­traZeneca still has­n't re­sumed its vac­cine tri­al in the US

Pfiz­er CEO Al­bert Bourla has made a point since the pan­dem­ic’s ear­ly days of re­ject­ing US as­sis­tance for their Covid-19 vac­cine, sep­a­rat­ing them from the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.